618 related articles for article (PubMed ID: 33503451)
41. Old Drugs To Treat Resistant Bugs: Methicillin-Resistant Staphylococcus aureus Isolates with mecC Are Susceptible to a Combination of Penicillin and Clavulanic Acid.
Ba X; Harrison EM; Lovering AL; Gleadall N; Zadoks R; Parkhill J; Peacock SJ; Holden MT; Paterson GK; Holmes MA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7396-404. PubMed ID: 26392513
[TBL] [Abstract][Full Text] [Related]
42. Emergence of Oxacillin Resistance in Stealth Methicillin-Resistant
Goering RV; Swartzendruber EA; Obradovich AE; Tickler IA; Tenover FC
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109981
[No Abstract] [Full Text] [Related]
43. Frequent occurrence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) strains in two African countries.
Conceição T; Coelho C; de Lencastre H; Aires-de-Sousa M
J Antimicrob Chemother; 2015 Dec; 70(12):3200-4. PubMed ID: 26318189
[TBL] [Abstract][Full Text] [Related]
44. Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance.
Zhuang H; Chen M; Hu D; Liu L; Wu D; Zhang H; Wang Z; Jiang S; Chen Y; Zhu F; Hong Y; Lei T; Wang H; Sun L; Ji S; Yu Y; Chen Y
Int J Antimicrob Agents; 2024 Jul; 64(1):107185. PubMed ID: 38692492
[TBL] [Abstract][Full Text] [Related]
45. Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.
Fernandez R; Paz LI; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2014 Oct; 58(10):5736-46. PubMed ID: 25022592
[TBL] [Abstract][Full Text] [Related]
46. Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus.
Figueiredo TA; Ludovice AM; Sobral RG
Microb Drug Resist; 2014 Jun; 20(3):238-49. PubMed ID: 24799330
[TBL] [Abstract][Full Text] [Related]
47. Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
Renzoni A; Kelley WL; Rosato RR; Martinez MP; Roch M; Fatouraei M; Haeusser DP; Margolin W; Fenn S; Turner RD; Foster SJ; Rosato AE
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795377
[TBL] [Abstract][Full Text] [Related]
48. Clinical, Epidemiologic, and Laboratory Aspects of Methicillin-Resistant Staphylococcus aureus Infections.
Palavecino EL
Methods Mol Biol; 2020; 2069():1-28. PubMed ID: 31523762
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa.
Chung M; Kim CK; Conceição T; Aires-De-Sousa M; De Lencastre H; Tomasz A
J Antimicrob Chemother; 2016 Oct; 71(10):2804-9. PubMed ID: 27278899
[TBL] [Abstract][Full Text] [Related]
50. Genetic Diversity among Staphylococcus aureus Isolates Showing Oxacillin and/or Cefoxitin Resistance Not Linked to the Presence of
Argudín MA; Roisin S; Nienhaus L; Dodémont M; de Mendonça R; Nonhoff C; Deplano A; Denis O
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661881
[TBL] [Abstract][Full Text] [Related]
51. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?
Ortwine JK; Werth BJ; Sakoulas G; Rybak MJ
Drug Resist Updat; 2013; 16(3-5):73-9. PubMed ID: 24268586
[TBL] [Abstract][Full Text] [Related]
52. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
[TBL] [Abstract][Full Text] [Related]
53. A Nonclassical Mechanism of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus and Its Effect on Virulence.
Satishkumar N; Lai LY; Mukkayyan N; Vogel BE; Chatterjee SS
Microbiol Spectr; 2022 Dec; 10(6):e0228422. PubMed ID: 36314912
[TBL] [Abstract][Full Text] [Related]
54. Insights into the Roles of Lipoteichoic Acids and MprF in Bacillus subtilis.
Guyet A; Alofi A; Daniel RA
mBio; 2023 Feb; 14(1):e0266722. PubMed ID: 36744964
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of selection media for the detection of borderline MRSA.
Yamada K; Inuzuka K; Tatsumi N; Sanzen I; Ohkura T; Okamoto A; Hasegawa T; Ohta M
J Infect Chemother; 2010 Feb; 16(1):19-24. PubMed ID: 20072796
[TBL] [Abstract][Full Text] [Related]
56. Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
Therien AG; Huber JL; Wilson KE; Beaulieu P; Caron A; Claveau D; Deschamps K; Donald RG; Galgoci AM; Gallant M; Gu X; Kevin NJ; Lafleur J; Leavitt PS; Lebeau-Jacob C; Lee SS; Lin MM; Michels AA; Ogawa AM; Painter RE; Parish CA; Park YW; Benton-Perdomo L; Petcu M; Phillips JW; Powles MA; Skorey KI; Tam J; Tan CM; Young K; Wong S; Waddell ST; Miesel L
Antimicrob Agents Chemother; 2012 Sep; 56(9):4662-70. PubMed ID: 22710113
[TBL] [Abstract][Full Text] [Related]
57. The NaHCO
Ersoy SC; Manna AC; Proctor RA; Chambers HF; Harrison EM; Bayer AS; Cheung A
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0025222. PubMed ID: 35575577
[TBL] [Abstract][Full Text] [Related]
58. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
[TBL] [Abstract][Full Text] [Related]
59. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Tattevin P; Basuino L; Chambers HF
Res Microbiol; 2009 Apr; 160(3):187-92. PubMed ID: 19366630
[TBL] [Abstract][Full Text] [Related]
60. TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci.
Lee SH; Wang H; Labroli M; Koseoglu S; Zuck P; Mayhood T; Gill C; Mann P; Sher X; Ha S; Yang SW; Mandal M; Yang C; Liang L; Tan Z; Tawa P; Hou Y; Kuvelkar R; DeVito K; Wen X; Xiao J; Batchlett M; Balibar CJ; Liu J; Xiao J; Murgolo N; Garlisi CG; Sheth PR; Flattery A; Su J; Tan C; Roemer T
Sci Transl Med; 2016 Mar; 8(329):329ra32. PubMed ID: 26962156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
